Advertisement

Reactions Weekly

, Volume 1781, Issue 1, pp 122–122 | Cite as

Crizotinib/icotinib

Drug resistance and various toxicities: case report
Case report
  • 13 Downloads

Reference

  1. Yu L, et al. Case report tumor heterogeneity with novel met fusion showed different response to cabozantinib in non-small cell lung cancer. International Journal of Clinical and Experimental Medicine 12: 10983-10986, No. 8, 2019. Available from: URL: http://www.ijcem.com/files/ijcem0091591.pdf - China

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations